From building in a line-of-sight to cGMP during the creation of advanced technology platforms like SymphonX™ and MaruX™, to supporting the rollout of the first kojoX™ single use facility in Billingham, UK, Helen Bickley, FUJIFILM Biotechnologies Chief Quality Officer reflects on what these innovations mean for clients, the industry—and most importantly, patients.

Primary Interest(Required)
Segments(Required)
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy